NEUROINMUNOLOGÍA
Montreal Neurological Institute and Hospital
Montreal, CanadáPublications en collaboration avec des chercheurs de Montreal Neurological Institute and Hospital (1)
2019
-
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial
The Lancet Neurology, Vol. 18, Núm. 9, pp. 845-856